468 related articles for article (PubMed ID: 36902391)
1. Status of Metabolomic Measurement for Insights in Alzheimer's Disease Progression-What Is Missing?
Yin C; Harms AC; Hankemeier T; Kindt A; de Lange ECM
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902391
[TBL] [Abstract][Full Text] [Related]
2. The contributions of metabolomics in the discovery of new therapeutic targets in Alzheimer's disease.
Altiné-Samey R; Antier D; Mavel S; Dufour-Rainfray D; Balageas AC; Beaufils E; Emond P; Foucault-Fruchard L; Chalon S
Fundam Clin Pharmacol; 2021 Jun; 35(3):582-594. PubMed ID: 33484165
[TBL] [Abstract][Full Text] [Related]
3. Characterizing Alzheimer's disease through metabolomics and investigating anti-Alzheimer's disease effects of natural products.
Yi L; Liu W; Wang Z; Ren D; Peng W
Ann N Y Acad Sci; 2017 Jun; 1398(1):130-141. PubMed ID: 28632966
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the application of metabolomics to Alzheimer's Disease.
Trushina E; Mielke MM
Biochim Biophys Acta; 2014 Aug; 1842(8):1232-9. PubMed ID: 23816564
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic-guided discovery of Alzheimer's disease biomarkers from body fluid.
Enche Ady CNA; Lim SM; Teh LK; Salleh MZ; Chin AV; Tan MP; Poi PJH; Kamaruzzaman SB; Abdul Majeed AB; Ramasamy K
J Neurosci Res; 2017 Oct; 95(10):2005-2024. PubMed ID: 28301062
[TBL] [Abstract][Full Text] [Related]
6. NMR-based metabolomics in Alzheimer's disease research: a review.
Vignoli A; Tenori L
Front Mol Biosci; 2023; 10():1308500. PubMed ID: 38099198
[TBL] [Abstract][Full Text] [Related]
7. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
[TBL] [Abstract][Full Text] [Related]
8. Unbiased Metabolomic Investigation of Alzheimer's Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism.
Paglia G; Stocchero M; Cacciatore S; Lai S; Angel P; Alam MT; Keller M; Ralser M; Astarita G
J Proteome Res; 2016 Feb; 15(2):608-18. PubMed ID: 26717242
[TBL] [Abstract][Full Text] [Related]
9. Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer's Disease and MCI: A Review.
Rao RV; Subramaniam KG; Gregory J; Bredesen AL; Coward C; Okada S; Kelly L; Bredesen DE
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675177
[TBL] [Abstract][Full Text] [Related]
10. Next-generation biomarker discovery in Alzheimer's disease using metabolomics - from animal to human studies.
Hurtado MO; Kohler I; de Lange EC
Bioanalysis; 2018 Sep; 10(18):1525-1546. PubMed ID: 30198770
[TBL] [Abstract][Full Text] [Related]
11. Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models.
Reddy PH; McWeeney S
Neurobiol Aging; 2006 Aug; 27(8):1060-77. PubMed ID: 16157420
[TBL] [Abstract][Full Text] [Related]
12. Alterations in Peripheral Metabolites as Key Actors in Alzheimer's Disease.
Sheng C; Chu X; He Y; Ding Q; Jia S; Shi Q; Sun R; Song L; Du W; Liang Y; Chen N; Yang Y; Wang X
Curr Alzheimer Res; 2023; 20(6):379-393. PubMed ID: 37622711
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic Alterations in the Blood and Brain in Association with Alzheimer's Disease: Evidence from in vivo to Clinical Studies.
Sriwichaiin S; Chattipakorn N; Chattipakorn SC
J Alzheimers Dis; 2021; 84(1):23-50. PubMed ID: 34511504
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis, therapeutic strategies and biomarker development based on "omics" analysis related to microglia in Alzheimer's disease.
Gao C; Shen X; Tan Y; Chen S
J Neuroinflammation; 2022 Sep; 19(1):215. PubMed ID: 36058959
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics.
Barba I; Fernandez-Montesinos R; Garcia-Dorado D; Pozo D
J Cell Mol Med; 2008; 12(5A):1477-85. PubMed ID: 18554316
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic Signatures of Alzheimer's Disease Indicate Brain Region-Specific Neurodegenerative Progression.
Ambeskovic M; Hopkins G; Hoover T; Joseph JT; Montina T; Metz GAS
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834217
[TBL] [Abstract][Full Text] [Related]
17. Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease.
Horgusluoglu E; Neff R; Song WM; Wang M; Wang Q; Arnold M; Krumsiek J; Galindo-Prieto B; Ming C; Nho K; Kastenmüller G; Han X; Baillie R; Zeng Q; Andrews S; Cheng H; Hao K; Goate A; Bennett DA; Saykin AJ; Kaddurah-Daouk R; Zhang B; ;
Alzheimers Dement; 2022 Jun; 18(6):1260-1278. PubMed ID: 34757660
[TBL] [Abstract][Full Text] [Related]
18. Application of Metabolomics in Alzheimer's Disease.
Wilkins JM; Trushina E
Front Neurol; 2017; 8():719. PubMed ID: 29375465
[TBL] [Abstract][Full Text] [Related]
19. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.
González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2395-402. PubMed ID: 25281826
[TBL] [Abstract][Full Text] [Related]
20. Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach.
Calabrese V; Scapagnini G; Colombrita C; Ravagna A; Pennisi G; Giuffrida Stella AM; Galli F; Butterfield DA
Amino Acids; 2003 Dec; 25(3-4):437-44. PubMed ID: 14661103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
